RPRX logo

Royalty Pharma plc (RPRX)

Profile

Full Name

Royalty Pharma plc

Ticker

NASDAQ: RPRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 16, 2020

Indexes

Not included

Website

http://www.royaltypharma.com

Employees

75

Key Details

Price

$37.12(-0.40%)

Market cap

Last Dividend

$0.22

TTM Dividend yield

2.32%

Annual revenue

$2.26B(-3.86% YoY)

Annual EPS

$1.91(-24.51% YoY)

PE ratio

15.84

Next earnings date

Aug 6, 2025

Next ex-dividend date

Aug 15, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.12
    RPRX price is $37.12

    30-Day Relative Volume

    0.81
    RPRX 30-day relative volume is 0.81

    Price Performance

    Price Most recent change

    -0.4%
    RPRX price was down -0.4% on Jul 30, 2025

    Price YTD change

    +45.51%
    RPRX price is up +45.51% since January 1st

    Price 1-year change

    +30.06%
    RPRX price is up +30.06% year-on-year

    Price 3-year change

    -14.65%
    RPRX price is down -14.65% over the past 3 years

    Price Range

    Price All-time high

    $56.50
    RPRX price is currently -34.30% below its historical high of $56.50

    Price 3-year low

    $24.05
    RPRX price is currently +54.35% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.64B
    RPRX market capitalization is $15.64 billion

    Market cap 3-year change

    -17.73%
    RPRX market capitalization is down -17.73% over the past 3 years

    Market cap All-time high

    $20.50B
    RPRX market capitalization is currently -23.71% below its historical high of $20.50 billion

    Market cap sector rank

    94.81%
    RPRX market capitalization is higher than 94.81% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -6.17%
    RPRX shares outstanding is down -6.17% year-on-year

    Shares Outstanding 3-Year Change

    -3.61%
    RPRX shares outstanding is down -3.61% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.27
    RPRX beta is 0.27

    200-day SMA

    $31.09
    RPRX price is currently +19.40% above its 200-day simple moving average

    50-day SMA

    $34.95
    RPRX price is currently +6.20% above its 50-day simple moving average

    RSI

    64.86
    RPRX 14-day relative strength index is 64.86

    Volume

    0.81
    RPRX 30-day relative volume is 0.81

    ATR

    $0.58
    RPRX average true range is $0.58

    10-day Historical Volatility

    11.11%
    RPRX 10-day historical volatility is 11.11%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.22
    RPRX last dividend was $0.22 per share, with an ex-dividend date of May 16, 2025

    Next Dividend

    $0.22
    RPRX has announced a dividend of $0.22 per share, with an ex-dividend date set for August 15, 2025

    Dividend per share

    Dividend per share

    $0.84
    RPRX annual dividend per share is $0.84

    Dividend per share Sector Rank

    36.05%
    RPRX annual dividend per share is higher than 36.05% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5%
    RPRX annual dividend per share is up +5% year-on-year

    Dividend per share 3-Year Change

    +23.53%
    RPRX annual dividend per share is up +23.53% over the past 3 years

    Dividend yield

    Dividend yield

    2.26%
    RPRX annual dividend yield is 2.26%

    Dividend yield Sector Rank

    54.12%
    RPRX annual dividend yield is higher than 54.12% of companies in Healthcare sector

    Other

    Payout ratio

    43.83%
    RPRX annual payout ratio is 43.83%

    Dividends paid

    $376.46M
    RPRX annual dividends paid is $376.46 million

    Free cash flow

    $2.77B
    RPRX annual free cash flow is $2.77 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.26B
    RPRX annual revenue is $2.26 billion

    Revenue Analysts estimate

    $3.06B
    RPRX annual revenue is currently -26.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    -3.86%
    RPRX annual revenue is down -3.86% year-on-year

    Revenue Sector rank

    85.81%
    RPRX annual revenue is higher than 85.81% of companies in Healthcare sector

    EPS

    EPS

    $1.91
    RPRX annual earnings per share is $1.91

    EPS Analysts estimate

    $4.40
    RPRX annual earnings per share is currently -56.62% lower than the consensus analysts' forecast

    EPS 1-year change

    -24.51%
    RPRX annual earnings per share is down -24.51% year-on-year

    EPS Sector rank

    91.85%
    RPRX annual earnings per share is higher than 91.85% of companies in Healthcare sector

    Profit

    Gross profit

    -
    RPRX annual gross profit value is unknown

    Gross margin

    -
    RPRX annual gross profit margin value is unknown

    Operating profit

    $1.29B
    RPRX annual operating income is $1.29 billion

    Operating margin

    57.10%
    RPRX annual operating profit margin is 57.10%

    Net income

    $858.98M
    RPRX annual net profit is $858.98 million

    Net margin

    37.95%
    RPRX annual net profit margin is 37.95%

    Expenses

    Total expenses

    $971.13M
    RPRX annual total expenses is $971.13 million

    Operating expenses

    $971.13M
    RPRX annual total operating expenses is $971.13 million

    Cost of goods sold

    -
    RPRX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $236.67M
    RPRX annual SGA is $236.67 million

    Depreciation and amortization

    $0.00
    RPRX annual depreciation & amortization is $0.00

    Interest expense

    $225.51M
    RPRX annual interest expense is $225.51 million

    Income tax

    $0.00
    RPRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    $1.56B
    RPRX annual earnings before interest & taxes is $1.56 billion

    EBITDA

    $1.56B
    RPRX annual EBITDA is $1.56 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $18.22B
    RPRX annual total assets is $18.22 billion

    Non current assets

    $16.42B
    RPRX annual long term assets is $16.42 billion

    Current assets

    $1.80B
    RPRX annual total current assets is $1.80 billion

    Cash and cash equivalents

    $929.03M
    RPRX annual cash & cash equivalents is $929.03 million

    Accounts receivable

    -
    RPRX annual accounts receivable value is unknown

    Inventory

    -
    RPRX annual inventory value is unknown

    Liabilities

    Total liabilities

    $7.88B
    RPRX annual total liabilities is $7.88 billion

    Long term liabilities

    $6.63B
    RPRX annual total long term liabilities is $6.63 billion

    Current liabilities

    $1.25B
    RPRX annual total current liabilities is $1.25 billion

    Accounts payable

    $13.37M
    RPRX annual accounts payable is $13.37 million

    Debt

    Total debt

    $7.61B
    RPRX annual total debt is $7.61 billion

    Total debt 1-year change

    +24.08%
    RPRX annual total debt is up +24.08% year-on-year

    Long term debt

    $6.61B
    RPRX annual long term debt is $6.61 billion

    Short term debt

    $997.77M
    RPRX annual short term debt is $997.77 million

    Equity & Capital

    Shareholders equity

    $6.95B
    RPRX annual stockholders equity is $6.95 billion

    Book value

    $6.95B
    RPRX annual book value is $6.95 billion

    Retained earnings

    $2.85B
    RPRX annual retained earnings is $2.85 billion

    Working capital

    $548.52M
    RPRX annual working capital is $548.52 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $2.77B
    RPRX annual cash flow from operations is $2.77 billion

    Cash from operations 1-year change

    -7.32%
    RPRX annual cash flow from operations is down -7.32% year-on-year

    Cash from investing

    -$2.68B
    RPRX annual cash flow from investing activities is -$2.68 billion

    Cash from investing 1-year change

    -29.2%
    RPRX annual cash flow from investing activities is down -29.2% year-on-year

    Cash from financing

    $361.14M
    RPRX annual cash flow from financing activities is $361.14 million

    Cash from financing 1-year change

    +116.81%
    RPRX annual cash flow from financing activities is up +116.81% year-on-year

    CAPEX

    CAPEX

    -
    RPRX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    RPRX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    $2.77B
    RPRX annual free cash flow is $2.77 billion

    Free cash flow 1-year change

    -7.32%
    RPRX annual free cash flow is down -7.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    RPRX annual gross profit margin value is unknown

    Operating margin

    57.10%
    RPRX annual operating profit margin is 57.10%

    Net margin

    37.95%
    RPRX annual net profit margin is 37.95%

    ROA & ROE

    ROA

    4.96%
    RPRX annual return on assets is 4.96%

    ROE

    8.41%
    RPRX annual return on equity is 8.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    15.84
    RPRX price to earnings ratio is 15.84

    PE ratio Sector rank

    31.13%
    RPRX price to earnings ratio is higher than 31.13% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.34
    RPRX price to book ratio is 2.34

    PB ratio Sector rank

    60.96%
    RPRX price to book ratio is higher than 60.96% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.91
    RPRX price to sales ratio is 6.91

    PS ratio Sector rank

    69.51%
    RPRX price to sales ratio is higher than 69.51% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $22.17B
    RPRX enterprise value is $22.17 billion

    Enterprise value Sector rank

    95.16%
    RPRX enterprise value is higher than 95.16% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    11.00
    RPRX EV/EBITDA is 11.00

    EV/EBITDA Sector rank

    84.67%
    RPRX EV/EBITDA is higher than 84.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.44
    RPRX annual current ratio is 1.44

    Quick ratio

    -
    RPRX annual quick ratio value is unknown

    Leverage

    Debt to equity

    1.10
    RPRX annual debt to equity ratio is 1.10

    Interest coverage ratio

    6.90
    RPRX annual interest coverage ratio is 6.90

    Risk & Stability

    Piotroski F-Score

    -
    RPRX piotroski f-score value is unknown

    Altman Z-Score

    1.85
    RPRX altman z-score is 1.85

    Analyst ratings

    Recent major analysts updates

    Jul 22, 25 Citigroup
    Buy
    Jul 10, 25 Morgan Stanley
    Overweight
    Oct 25, 24 Citigroup
    Buy
    Aug 14, 24 Goldman Sachs
    Buy
    Jul 11, 24 Morgan Stanley
    Overweight
    Jun 3, 24 UBS
    Neutral
    Apr 12, 24 B of A Securities
    Buy
    Feb 20, 24 JP Morgan
    Overweight
    Feb 20, 24 Goldman Sachs
    Buy
    Nov 9, 23 Morgan Stanley
    Overweight

    Institutional Ownership

    Screeners with RPRX included

    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    Companies with growing dividends
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    • What is the ticker symbol for Royalty Pharma plc?
    • Does Royalty Pharma plc pay dividends?
    • What sector is Royalty Pharma plc in?
    • What industry is Royalty Pharma plc in?
    • What country is Royalty Pharma plc based in?
    • When did Royalty Pharma plc go public?
    • Is Royalty Pharma plc in the S&P 500?
    • Is Royalty Pharma plc in the NASDAQ 100?
    • Is Royalty Pharma plc in the Dow Jones?
    • When was Royalty Pharma plc's last earnings report?
    • When does Royalty Pharma plc report earnings?

    What is the ticker symbol for Royalty Pharma plc?

    The ticker symbol for Royalty Pharma plc is NASDAQ:RPRX

    Does Royalty Pharma plc pay dividends?

    Yes, Royalty Pharma plc pays dividends. The last payment was $0.22, with an ex-dividend date on May 16, 2025

    What sector is Royalty Pharma plc in?

    Royalty Pharma plc is in the Healthcare sector

    What industry is Royalty Pharma plc in?

    Royalty Pharma plc is in the Biotechnology industry

    What country is Royalty Pharma plc based in?

    Royalty Pharma plc is headquartered in United States

    When did Royalty Pharma plc go public?

    Royalty Pharma plc's initial public offering (IPO) was on June 16, 2020

    Is Royalty Pharma plc in the S&P 500?

    No, Royalty Pharma plc is not included in the S&P 500 index

    Is Royalty Pharma plc in the NASDAQ 100?

    No, Royalty Pharma plc is not included in the NASDAQ 100 index

    Is Royalty Pharma plc in the Dow Jones?

    No, Royalty Pharma plc is not included in the Dow Jones index

    When was Royalty Pharma plc's last earnings report?

    Royalty Pharma plc's most recent earnings report was on May 8, 2025

    When does Royalty Pharma plc report earnings?

    The next expected earnings date for Royalty Pharma plc is August 6, 2025
    On this page